Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis

BACKGROUND: Although adjuvant transcatheter arterial chemoembolization (TACE) has been used to prevent recurrence after surgery in patients with hepatocellular carcinoma (HCC), the survival benefits from adjuvant TACE remain controversial. We sought to systematically evaluate the data on the effecti...

Full description

Saved in:
Bibliographic Details
Published in:Therap Adv Gastroenterol
Main Authors: Liang, Lei, Li, Chao, Diao, Yong-Kang, Jia, Hang-Dong, Xing, Hao, Pawlik, Timothy M., Lau, Wan Yee, Shen, Feng, Huang, Dong-Sheng, Zhang, Cheng-Wu, Yang, Tian
Format: Artigo
Language:Inglês
Published: SAGE Publications 2020
Subjects:
Diagnosis, Management, and Prognostic Assessment of Liver Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720303/
https://ncbi.nlm.nih.gov/pubmed/33329759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284820977693
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items